Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
John R. Mehall: The Importance of Anticoagulation Management in ECMO
John R. Mehall and Neil Honey/LinkedIn
Sep 5, 2026, 19:18

John R. Mehall: The Importance of Anticoagulation Management in ECMO

John R. Mehall, President of Integration Health, Senior Vice President of Heart and Vascular Partners, Co-Founder of Pacific Tarn Capital, Advanced CV Fellow at HaloDx, shared Neil Honey‘s post on LinkedIn:

“Anticoagulation management is a critical skill in ECMO.

When done well, it can extend the life of circuits and oxygenators, reducing the risk of changing them and saving money.”

Neil Honey, Director of Partnerships and Digital Marketing at Integration Health, Realtor at Kerr and Co. Realty, shared a post on LinkedIn:

“TEG in ECMO: Are you using it in your program?

Integration Health‘s August newsletter takes a closer look at thromboelastography testing and how real-time assessment of hemostasis can help inform clinical decision-making throughout the patient’s ECMO course.

But we want to hear from the people actually at the bedside:

Is your ECMO program using TEG?

  • If so, how are you incorporating it into your practice?
  • If not, what’s holding your program back?

Join the conversation and tell us what you’re seeing in your program.”

John R. Mehall

Stay updated with Hemostasis Today.

Anticoagulation Anticoagulation Management Blood Cardiology ECMO Health Hematology Hemostasis Hemostasis News Hemostasis Today Integration Health John R. Mehall Medicine TEG thromboelastography
NewsFeed